Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene

Kathrin A Schmohl, Aayush Gupta, Geoffrey K Grünwald, Marija Trajkovic-Arsic, Kathrin Klutz, Rickmer Braren, Markus Schwaiger, Peter J Nelson, Manfred Ogris, Ernst Wagner, Jens T Siveke, Christine Spitzweg

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Pages (from-to)33393-33404
    Number of pages12
    JournalOncotarget
    Volume8
    Issue number20
    DOIs
    Publication statusPublished - 2017

    Austrian Fields of Science 2012

    • 301207 Pharmaceutical chemistry

    Keywords

    • Journal Article
    • CELLS
    • gene therapy
    • EGFR-targeting
    • sodium iodide symporter
    • genetically engineered mouse model
    • pancreatic ductal adenocarcinoma
    • LIVER-CANCER
    • GROWTH-FACTOR RECEPTOR
    • INHIBITION
    • RADIOIODINE THERAPY
    • MOUSE MODEL
    • PROSTATE-CANCER
    • HEPATOCELLULAR CANCER
    • SYSTEMIC NONVIRAL DELIVERY
    • EGF RECEPTOR
    • Genetically engineered mouse model
    • Pancreatic ductal adenocarcinoma
    • Sodium iodide symporter
    • Gene therapy

    Fingerprint

    Dive into the research topics of 'Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene'. Together they form a unique fingerprint.

    Cite this